| |
|
|
| Name: |
CHI Advisors LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10022 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
29 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
PLRX |
Pliant Therapeutics, Inc. |
1 |
- |
$0.00 |
$52,266,000 |
3,014,199 |
20.73% |
-4,214,000 |
-102,818 |
4.792 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
2 |
- |
$0.00 |
$35,837,000 |
2,966,674 |
14.22% |
4,110,000 |
-32,060 |
8.073 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
3 |
- |
$0.00 |
$30,898,000 |
3,414,189 |
12.26% |
-5,839,000 |
0 |
7.845 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
4 |
- |
$4.24 |
$23,015,000 |
2,262,990 |
9.13% |
-32,659,000 |
-400,816 |
2.328 |
N/A |
|
|
ORTX |
Orchard Therapeutics Plc |
5 |
- |
$0.00 |
$14,035,000 |
12,315,654 |
5.57% |
10,098,000 |
11,559,916 |
66.933 |
N/A |
|
|
LRMR |
Larimar Therapeutics Inc |
6 |
- |
$1.15 |
$13,487,000 |
3,414,468 |
5.35% |
4,767,000 |
0 |
8.549 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
7 |
- |
$0.00 |
$12,995,000 |
407,633 |
5.15% |
-3,162,000 |
5,515 |
1.2 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
8 |
- |
$0.00 |
$9,443,000 |
2,180,934 |
3.75% |
-4,478,000 |
58,894 |
7.241 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
9 |
- |
$44.24 |
$7,665,000 |
215,000 |
3.04% |
3,744,000 |
130,000 |
0.315 |
Restaurants |
|
|
CMPX |
Compass Therapeutics Ord Shs |
10 |
- |
$0.00 |
$5,575,000 |
2,829,712 |
2.21% |
-3,423,000 |
0 |
2.887 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
11 |
New |
$0.00 |
$5,405,000 |
568,379 |
2.14% |
5,405,000 |
568,379 |
1.391 |
N/A |
|
|
INZY |
Inozyme Pharma, Inc. |
12 |
- |
$0.00 |
$5,334,000 |
1,270,027 |
2.12% |
-1,322,000 |
75,000 |
2.056 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
13 |
- |
$5.04 |
$5,119,000 |
1,299,359 |
2.03% |
2,702,000 |
531,914 |
2.312 |
N/A |
|
|
BPMC |
Blueprint Medicines Corp |
14 |
New |
$93.00 |
$4,665,000 |
92,888 |
1.85% |
4,665,000 |
92,888 |
0.141 |
N/A |
|
|
LABD |
Direxion Daily S&p Biotech ... |
15 |
- |
$10.52 |
$4,635,000 |
225,000 |
1.84% |
-35,000 |
-100,000 |
0.779 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
16 |
- |
$0.00 |
$3,928,000 |
1,002,007 |
1.56% |
-4,694,000 |
150,000 |
1.928 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
17 |
New |
$0.00 |
$3,420,000 |
60,000 |
1.36% |
3,420,000 |
60,000 |
0.146 |
N/A |
|
|
OVID |
Ovid Therapeutics Inc. |
18 |
- |
$3.10 |
$3,321,000 |
864,822 |
1.32% |
484,000 |
0 |
1.363 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
19 |
New |
$4.06 |
$3,070,000 |
348,842 |
1.22% |
3,070,000 |
348,842 |
1.633 |
N/A |
|
|
OMGA |
Omega Therapeutics, Inc. |
20 |
- |
$2.27 |
$2,270,000 |
1,055,882 |
0.9% |
-3,643,000 |
0 |
2.002 |
N/A |
|
|
BDTX |
Black Diamond Therapeutics,... |
21 |
- |
$5.89 |
$2,066,000 |
720,000 |
0.82% |
-1,722,000 |
-30,000 |
2 |
N/A |
|
|
RLYB |
Rallybio Corp |
22 |
- |
$0.00 |
$1,317,000 |
390,734 |
0.52% |
-1,755,000 |
-152,040 |
1.132 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
23 |
- |
$27.55 |
$1,175,000 |
25,000 |
0.47% |
-4,381,000 |
-100,139 |
0.144 |
N/A |
|
|
GRPH |
Graphite Bio, Inc. |
24 |
- |
$0.00 |
$573,000 |
230,938 |
0.23% |
-27,000 |
0 |
0.398 |
N/A |
|
|
FRLN |
Freeline Therapeutics Hldgs |
25 |
- |
$0.00 |
$373,000 |
86,654 |
0.15% |
373,000 |
86,654 |
0.139 |
N/A |
|
|
DTIL |
Precision Biosciences Inc |
26 |
- |
$11.60 |
$6,900 |
20,221 |
0.08% |
-636,000 |
-33,231 |
0.547 |
N/A |
|
|
CRVS |
Corvus Pharmaceuticals, Inc. |
29 |
Closed |
$1.45 |
$0 |
0 |
0% |
-458,000 |
-200,000 |
0 |
N/A |
|
|
VECT |
Vectivbio Holding Ord Shs |
28 |
Closed |
$0.00 |
$0 |
0 |
0% |
-46,945,000 |
-2,782,756 |
0 |
N/A |
|
|
HOOK |
Hookipa Pharma Inc. |
27 |
Closed |
$0.00 |
$0 |
0 |
0% |
-694,000 |
-788,740 |
0 |
N/A |
|
